These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1424863)

  • 21. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health.
    Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
    J Am Acad Dermatol; 2017 Jan; 76(1):1-9. PubMed ID: 27986132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid-induced osteoporosis.
    Compston J
    Horm Res; 2003; 60 Suppl 3():77-9. PubMed ID: 14671402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosteroid-induced osteoporosis.
    Adachi JD; Bensen WG; Cividino A
    J Am Med Womens Assoc (1972); 1998; 53(1):25-30, 40. PubMed ID: 9458622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases.
    Gluck O; Colice G
    Chest; 2004 May; 125(5):1859-76. PubMed ID: 15136401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortisol mobilizes mineral stores from vertebral skeleton in the European eel: an ancestral origin for glucocorticoid-induced osteoporosis?
    Sbaihi M; Rousseau K; Baloche S; Meunier F; Fouchereau-Peron M; Dufour S
    J Endocrinol; 2009 May; 201(2):241-52. PubMed ID: 19223398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glucocorticoid-induced osteoporosis].
    Foltyn W; Kos-Kudła B; Marek B; Kajdaniuk D; Głogowska-Szelag J; Siemińska L; Strzelczyk J; Borowska M
    Endokrynol Pol; 2007; 58(2):170-5. PubMed ID: 17578833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Steroids as a risk factor for osteoporotic fracture].
    Muraki S; Yoshimura N
    Clin Calcium; 2006 Nov; 16(11):1797-1803. PubMed ID: 17079845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Kao NL; Richmond GW
    Chest; 1993 Dec; 104(6):1936. PubMed ID: 8252998
    [No Abstract]   [Full Text] [Related]  

  • 30. Glucocorticoid induced risk of fractures.
    Maruotti N; Corrado A; Cantatore FP
    Panminerva Med; 2010 Dec; 52(4):339-43. PubMed ID: 21183894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
    Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of guidelines on glucocorticoid-induced osteoporosis: comment on the American College of Rheumatology Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.
    Buckley LM
    Arthritis Rheum; 1997 Aug; 40(8):1547. PubMed ID: 9259442
    [No Abstract]   [Full Text] [Related]  

  • 33. [Glucocorticoid induced osteoporosis].
    Anić B; Mayer M
    Reumatizam; 2014; 61(2):105-12. PubMed ID: 25427404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid-induced osteoporosis and its treatment.
    Pennisi P; Trombetti A; Rizzoli R
    Clin Orthop Relat Res; 2006 Feb; 443():39-47. PubMed ID: 16462424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid induced osteoporosis.
    Pranić-Kragić A; Radić M; Martinović-Kaliterna D; Radić J
    Acta Clin Croat; 2011 Dec; 50(4):563-6. PubMed ID: 22649887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Doga M; Mazziotti G; Bonadonna S; Patelli I; Bilezikian JP; Canalis E; Giustina A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):53-8. PubMed ID: 18791353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid-induced osteoporosis: pathophysiology and therapy.
    Canalis E; Mazziotti G; Giustina A; Bilezikian JP
    Osteoporos Int; 2007 Oct; 18(10):1319-28. PubMed ID: 17566815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid-induced osteoporosis.
    Saag KG
    Endocrinol Metab Clin North Am; 2003 Mar; 32(1):135-57, vii. PubMed ID: 12699296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piper sarmentosum prevents glucocorticoid-induced osteoporotic bone resorption by increasing 11β-hydroxysteroid dehydrogenase type 1 activity.
    Suhana MR; Farihah HS; Faizah O; Nazrun SA; Norazlina M; Norliza M; Nirwana SI
    Clin Ter; 2011; 162(4):313-8. PubMed ID: 21912818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.